NY A06564

Establishes "Collaborative Practice Medication Adherence Act" allowing qualified pharmacists to work under written protocols with physicians to manage chronic disease medications for patients who have not met treatment goals or face hospitalization risk.

Requires qualified pharmacists to have an active license, minimum two years of patient care experience within the last five years, and demonstrated competency in medication adherence through accredited programs.

Permits qualified pharmacists under protocols to adjust drug strength, frequency, or administration route; order disease-related laboratory tests; perform patient monitoring functions; and access patient medical records with physician notification of changes.

Prohibits pharmacists from substituting different drugs unless expressly authorized by the physician's written order and bars delegation of these services to other pharmacy personnel.

Makes permanent the provisions of chapter 21 of the laws of 2011 authorizing pharmacists to perform collaborative drug therapy management with physicians, removing the previous July 1, 2024 expiration date.